无锡药明康德新药开发股份有限公司（简称“药明康德”，股票代码：02359）于2026年9月4日在香港联合交易所发布翌日披露报表，宣布因人民币67.80亿元2027年到期的美元结算零息可转换债券转换，增发了6,827,131股H股，占原本已发行股份约1.34%。每股发行价格为153港元。此次增发完成后，公司已发行股份（不包括库藏股）由2026年9月3日的511,126,247股增至517,953,378股，库藏股仍为20,148,900股，总股本相应增加至538,102,278股。
公司在公告中确认，已遵守香港联合交易所证券上市规则及相关法律法规的所有适用规定。该公告由董事李革签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.